A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. - Wikidata - wikimedia - TriplyDB

A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.

A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.

http://www.wikidata.org/entity/Q39102559

about

Management of bleeding and coagulopathy following major trauma: an updated European guideline.Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders Anti-fibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders Methods to decrease blood loss and transfusion requirements for liver transplantation Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion Antiproteases for acute pancreatitis Platelet-rich-plasmapheresis for minimising peri-operative allogeneic blood transfusion Cell salvage for minimising perioperative allogeneic blood transfusion Desmopressin for minimising perioperative allogeneic blood transfusion Platelet-rich-plasmapheresis for minimising peri-operative allogeneic blood transfusion Prediction and Prevention of Acute Kidney Injury after Cardiac Surgery Massive haemorrhage in liver transplantation: Consequences, prediction and management Reducing transfusion requirements in liver transplantation Is sustained virological response a marker of treatment efficacy in patients with chronic hepatitis C viral infection with no response or relapse to previous antiviral intervention?Ventricular assist devices: pharmacological aspects of a mechanical therapy Haemostatic management of cardiac surgical haemorrhage The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition Self-propelled particles that transport cargo through flowing blood and halt hemorrhage.The structure of Human Microplasmin in Complex with Textilinin-1, an Aprotinin-like Inhibitor from the Australian Brown Snake Strategies for blood conservation in pediatric cardiac surgery A 2014 Update on Coagulation Management for Cardiopulmonary Bypass.Procoagulant therapeutics in liver disease: a critique and clinical rationale.Transfusion and hematologic variables after fibrinogen or platelet transfusion in valve replacement surgery: preliminary data of purified lyophilized human fibrinogen concentrate versus conventional transfusion.Systematic review and meta-analysis of the use of tranexamic acid in tonsillectomy.The GRADE system for rating clinical guidelines.Contribution of endogenous bradykinin to fibrinolysis, inflammation, and blood product transfusion following cardiac surgery: a randomized clinical trial.Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis.Management of Blood Loss in Hip Arthroplasty: Korean Hip Society Current Consensus.Aprotinin protects the cerebral microcirculation during cardiopulmonary bypass.Antifibrinolytics in liver surgery.Perioperative blood management strategies for patients undergoing total knee replacement: Where do we stand now?Temporally and regionally disparate differences in plasmin activity by tranexamic acid.Management of bleeding following major trauma: an updated European guideline.Tranexamic acid and trauma-induced coagulopathy.Interstitial plasmin activity with epsilon aminocaproic acid: temporal and regional heterogeneity.Trends in acute kidney injury, associated use of dialysis, and mortality after cardiac surgery, 1999 to 2008.A Brief History of Cardiopulmonary Bypass.Plasma cystatin C and acute kidney injury after cardiopulmonary bypass.Acute Effect of Intravenous Administration of Magnesium Sulfate on Serum Levels of Interleukin-6 and Tumor Necrosis Factor-α in Patients Undergoing Elective Coronary Bypass Graft With Cardiopulmonary Bypass

P2860

Q21092902-B0186C73-23EB-46DE-9079-70AFAB3FD42C Q24186028-9D6E226C-CD7A-46C4-BAE4-BE167D49677C Q24201018-8DEA0801-D265-4D5A-B990-83A19A5E4432 Q24201514-F4F5A27D-7C4D-4D20-96D2-584B05D2DD0F Q24234278-DF85B873-1D43-4D93-82C5-03C3EA5052EA Q24235627-3BD129EC-98EC-470F-894E-76D62E763964 Q24235717-4E7176E4-D86A-4E89-B996-714BBED03D24 Q24235886-F48B4894-4B58-4BA2-A079-852C2A023F80 Q24235950-EFDB6893-4876-4A66-A62D-87A9ADD5156F Q24247402-E98688E9-4C23-4553-836D-46DC0E576D2B Q24250237-D4CCA9B2-AFEA-4A1E-A236-383C4A1904BD Q26740134-F82E281F-D2C6-43BF-9EFB-DE5262835CFB Q26745966-4B52BD7A-03D0-4C30-A520-20B85195C0BE Q26771408-B62ACE83-3A39-4DB0-914A-00FEFFE26C93 Q26830804-B45305CC-9C29-40A7-90F0-048D6AC33844 Q27002612-ABDD3FB6-B5DD-48B9-B9E9-C7CC95A85F3D Q27024386-94A5F7A6-8437-4F79-A18F-A63F306EC18D Q27339343-4ABF7D0D-9DDF-4374-9DBC-551B5B73AD0D Q27340130-92C375F1-CA89-4971-903D-1C4B87A96560 Q27675944-116BAE02-59AA-421A-98A0-482575D364F1 Q28075771-AE90FD05-25DB-4E7C-A9C3-ECF46DE1A171 Q30458252-DED3D6BE-D222-45EA-897E-9413C7155277 Q30458618-1E439E00-B265-4E2D-9CB2-F668402B57E9 Q30635705-1D38FF3E-1BDE-4BA5-A3C5-72C341FCA55C Q31097083-01225CDA-174E-4CC9-934A-0328E5BC2210 Q33503214-DC14F86F-10C0-4BBB-A34D-E87B2D043060 Q33652707-774F1C18-55C2-48EA-814E-27ABD4717249 Q33676496-AC182330-BAC1-42E2-B42D-340522436166 Q33781089-E2BD3861-6052-44BD-8E67-04947E60DC3D Q33782785-D870ACB3-79F1-49F7-916D-17703444981E Q33790811-36DF207A-6914-4DCD-8256-D0C86F994D52 Q33818396-27B15787-1E6A-4A6C-8763-4DE926837BD6 Q33893325-CA22DA70-33ED-44A1-A005-8C710AF6F15B Q33919178-F5A193E1-13C7-4C74-BAF6-370D2254FB0E Q33919354-95F0F8D0-06E4-4EA0-8154-A070B47AAF07 Q33932489-6CD1DDAE-08B7-4221-8555-08C4595B9002 Q33971106-3A0B63E3-3BB6-4A70-86C0-11DE7B21B596 Q34040597-FC0BB3F7-0DD4-4438-8530-27F7A09A50E7 Q34075458-C9EA08C9-2394-442A-8722-92ECB4A1272E Q34186308-6FF2D50B-FD69-4513-B50E-C1908B71409F

P2860

A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.

http://www.wikidata.org/entity/Q39102559

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.

@en

A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.

@nl

type

label

A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.

@en

A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.

@nl

prefLabel

A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.

@en

A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.

@nl

P1433

Q39102559-A71FB7B1-7F3B-404F-9BB6-25CBE23CCA1C

P1476

Q39102559-C8D4A951-4BE8-4BD2-95C5-EFC573C6A6D0

P2093

Q39102559-01F3602E-4FB3-4DC1-BD96-7423CF23D43A

Q39102559-134FE8CB-678E-4A56-9ED6-CF41697AD73F

Q39102559-18F5EAC5-1B40-4232-B56D-3F6D9F586B24

Q39102559-25BB845C-55C5-4920-A797-94C200EA5D16

Q39102559-30D1F13C-B5FF-4D3C-AE4B-7238C1365BE7

Q39102559-3541B6F2-9ABF-48C2-9FFE-E5F26120F98D

Q39102559-45D9485C-9EB1-4199-830D-BFCCAD5BE8EB

Q39102559-64CBFCC5-E432-4048-A5A1-A21080ADE1E3

Q39102559-7CFD140F-DA2A-4595-98DA-23812FB55AFD

Q39102559-A3A696D2-BC43-4C57-A0FB-445C5F2F1578

P304

Q39102559-40CAE3A6-7C0A-4A28-90F6-90D9BDB013BC

P31

Q39102559-9DC24B99-A262-4820-A4CE-E92A7404E071

P356

Q39102559-BF22B149-DAC5-4AAB-9D0C-F99E6EC2A88E

P407

Q39102559-05086BA5-7636-495A-AAFD-9EFA2BF1BD62

P433

Q39102559-FEEC1DE8-5E00-445F-A9F5-34CA56C82B1D

P478

Q39102559-CF2A1570-7A9E-4ED7-9F0C-7302A93A060F

P50

Q39102559-26DB00A4-B29B-4D5B-BCDA-7F67A90DD0F0

Q39102559-625D1A67-F963-449E-A67B-43B855ECF3EA

P577

Q39102559-41C53B20-75BD-4A05-A577-BC22B2DFAB90

P5875

Q39102559-FB05DFFD-7EBB-4967-928E-DE5D02BAEEAB

P698

Q39102559-30E8BFF2-642B-469D-8AA5-A815F31722DB

P921

Q39102559-81D847D9-8C6D-4DE9-99D4-9EC293963E6C

P356

P1433

The New England Journal of Medicine

P1476

A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.

@en

P2093

BART Investigators

http://www.w3.org/2001/XMLSchema#string

C David Mazer

http://www.w3.org/2001/XMLSchema#string

Charles MacAdams

http://www.w3.org/2001/XMLSchema#string

Dany Côté

http://www.w3.org/2001/XMLSchema#string

George Wells

http://www.w3.org/2001/XMLSchema#string

Jacek Karski

http://www.w3.org/2001/XMLSchema#string

James A Robblee

http://www.w3.org/2001/XMLSchema#string

Jean S Bussières

http://www.w3.org/2001/XMLSchema#string

Jennifer Clinch

http://www.w3.org/2001/XMLSchema#string

John M Murkin

http://www.w3.org/2001/XMLSchema#string

P304

2319-2331

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA0802395

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

358

http://www.w3.org/2001/XMLSchema#string

P50

Stephen E. Fremes

Dean A Fergusson

P577

2008-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5371718

http://www.w3.org/2001/XMLSchema#string

P698

18480196

http://www.w3.org/2001/XMLSchema#string

P921

cardiac surgery